ELUCENIA
ELUCENIA
ELUCENIA / PREDICT Prostate

PREDICT Prostate · survival

Compare survival and mortality estimates with and without radical treatment using PREDICT Prostate 1.1. The tool does not choose a treatment.

Technical checks available; clinical and professional linguistic review have not been performed.

  1. Check the method
  2. Enter the data
  3. Review the result

PREDICT Prostate · survival

Compare survival and mortality estimates with and without radical treatment using PREDICT Prostate 1.1. The tool does not choose a treatment.

Data are processed on this ELUCENIA server and are not sent to the provider.

35–95
0–100
Include inpatient hospital admissions in the two years before diagnosis. Exclude admissions related to investigating or diagnosing this prostate cancer.
If only targeted-lesion biopsies were taken, select No. For systematic biopsies with MRI targets, each target counts as one core regardless of the number of samples. Without data, the model uses 41.9415% positive cores.
Conditions of use

For newly diagnosed men with non-metastatic prostate cancer when conservative and radical management are both appropriate options. Cohort estimates cannot guarantee an individual outcome. Harms and quality of life are not modeled. The interface supports ages 35–95, PSA 0–100 ng/mL and 10- or 15-year projections. Translation does not recalibrate the model for another country.

An intraductal or cribriform component requires consideration of its size, extent, grade assignment and biopsy sites. If significant, interpret with caution or do not use the output.

Technical checks available; clinical and professional linguistic review have not been performed.

CONNECT TO RESEARCH

My investigation

Organize resources for your scientific question. This selection stays in this browser and can be exported to plan the investigation with your team.

Explore Research Rooms ↗

This selection does not create a Research Room or send data to a team.